Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

177 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Premature cardiovascular mortality in lymphoma patients treated with (R)-CHOP regimen - a national multicenter study.
Jurczak W, Szmit S, Sobociński M, Machaczka M, Drozd-Sokołowska J, Joks M, Dzietczenia J, Wróbel T, Kumiega B, Zaucha JM, Knopińska-Posłuszny W, Spychałowicz W, Prochwicz A, Drohomirecka A, Skotnicki AB. Jurczak W, et al. Int J Cardiol. 2013 Oct 15;168(6):5212-7. doi: 10.1016/j.ijcard.2013.08.033. Epub 2013 Aug 15. Int J Cardiol. 2013. PMID: 23998543
Acute decompensated heart failure as a reason of premature chemotherapy discontinuation may be independent of a lifetime doxorubicin dose in lymphoma patients with cardiovascular disorders.
Szmit S, Jurczak W, Zaucha JM, Długosz-Danecka M, Sosnowska-Pasiarska B, Chmielowska E, Joks M, Drozd-Sokołowska J, Knopińska-Posłuszny W, Spychałowicz W, Kumiega B, Charliński G, Morawska M, Słomian G. Szmit S, et al. Among authors: jurczak w. Int J Cardiol. 2017 May 15;235:147-153. doi: 10.1016/j.ijcard.2017.02.073. Epub 2017 Feb 22. Int J Cardiol. 2017. PMID: 28268088
Early chemotherapy de-escalation strategy in patients with advanced-stage Hodgkin lymphoma with negative positron emission tomography scan after 2 escalated BEACOPP cycles.
Długosz-Danecka M, Szmit S, Kocurek A, Koźlik P, Giza A, Zimowska-Curyło D, Małkowski B, Sowa-Staszczak A, Kużdżał J, Jurczak W. Długosz-Danecka M, et al. Among authors: jurczak w. Pol Arch Intern Med. 2019 Apr 30;129(4):259-266. doi: 10.20452/pamw.14786. Epub 2019 Apr 4. Pol Arch Intern Med. 2019. PMID: 30945698 Free article.
Helping the cardio-oncologist: from real life to guidelines.
Armenian SH, Jurczak W, Carver JR, Gennari A, Minotti G, Ewer MS. Armenian SH, et al. Among authors: jurczak w. Semin Oncol. 2019 Dec;46(6):433-436. doi: 10.1053/j.seminoncol.2019.01.005. Epub 2019 Nov 20. Semin Oncol. 2019. PMID: 31784041 Review.
Cardio-oncology for better lymphoma therapy outcomes.
Jurczak W, Długosz-Danecka M, Szmit S. Jurczak W, et al. Lancet Haematol. 2020 Apr;7(4):e273-e275. doi: 10.1016/S2352-3026(20)30066-1. Epub 2020 Mar 2. Lancet Haematol. 2020. PMID: 32135129 No abstract available.
Copanlisib plus rituximab versus placebo plus rituximab in patients with relapsed indolent non-Hodgkin lymphoma (CHRONOS-3): a double-blind, randomised, placebo-controlled, phase 3 trial.
Matasar MJ, Capra M, Özcan M, Lv F, Li W, Yañez E, Sapunarova K, Lin T, Jin J, Jurczak W, Hamed A, Wang MC, Baker R, Bondarenko I, Zhang Q, Feng J, Geissler K, Lazaroiu M, Saydam G, Szomor Á, Bouabdallah K, Galiulin R, Uchida T, Soler LM, Cao A, Hiemeyer F, Mehra A, Childs BH, Shi Y, Zinzani PL. Matasar MJ, et al. Among authors: jurczak w. Lancet Oncol. 2021 May;22(5):678-689. doi: 10.1016/S1470-2045(21)00145-5. Epub 2021 Apr 10. Lancet Oncol. 2021. PMID: 33848462 Clinical Trial.
177 results